Litcius/Paper detail

Severity of Cytokine Release Syndrome Influences Outcome After Axicabtagene Ciloleucel for Large B cell Lymphoma: Results from the US Lymphoma CAR-T Consortium

Miriam T. Jacobs, Michael D. Jain, Feng Gao, Loretta J. Nastoupil, Jay Y. Spiegel, Yi Lin, Saurabh Dahiya, Matthew A. Lunning, Lazaros J. Lekakis, Patrick M. Reagan, Olalekan O. Oluwole, Joseph P. McGuirk, Abhinav Deol, Alison R. Sehgal, André Goy, Brian T. Hill, Charalambos Andreadis, Javier Muñoz, Julio C. Chávez, N. Nora Bennani, Aaron P. Rapoport, Julie M. Vose, David B. Miklos, Sattva S. Neelapu, Armin Ghobadi, Frederick L. Locke

2022Clinical Lymphoma Myeloma & Leukemia20 citationsDOI

Topics & Concepts

MedicineLymphomaChimeric antigen receptorInternal medicineCytokine release syndromePopulationCD19CohortOncologyAntigenGastroenterologyImmunologyImmunotherapyCancerEnvironmental healthCAR-T cell therapy researchLymphoma Diagnosis and TreatmentImmune Cell Function and Interaction